PubMed:33105485 / 1428-1633 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":80,"end":88},"obj":"Disease"},{"id":"T13","span":{"begin":168,"end":175},"obj":"Disease"},{"id":"T14","span":{"begin":189,"end":197},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"}],"text":"The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":49,"end":54},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":168,"end":175},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":"The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%)."}